MedPath
TGA Approval

OPDUALAG nivolumab 240mg and relatlimab 80mg in 20mL concentrate solution for IV infusion vial (372783)

372783

OPDUALAG nivolumab 240mg and relatlimab 80mg in 20mL concentrate solution for IV infusion vial

Bristol-Myers Squibb Australia Pty Ltd

October 7, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/fe1407221175da9e20cfb1b894853108.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/3ba313c10e543f13649f37cd26288a67.pdf

Active Ingredients

nivolumab

relatlimab

© Copyright 2025. All Rights Reserved by MedPath